TARS Tarsus Pharmaceuticals, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
19:04
Sep 04
Sep 04
Author clarifies that TARS is not being acquired and that BLTE's acquisition is a positive.
Author clarifies that TARS is not being acquired and that BLTE's acquisition is a positive read-through for TARS due to gildeuretinol, a factual context note.
19:03
Sep 04
Sep 04
Author clarifies TARS is not being acquired but notes BLTE's acquisition is a positive.
Author clarifies TARS is not being acquired but notes BLTE's acquisition is a positive read-through for TARS due to gildeuretinol, without stating a personal position.
LOW
18:51
Sep 04
Sep 04
Author avoids chasing BLTE and TARS due to suspicious trading.
Author avoids chasing BLTE and TARS due to suspicious trading, but plans to add XBI expecting M&A activity and a typical positive response.
LOW
06:36
Jul 27
Jul 27
The author dismisses TARS as having weak IP and suggests a buyout would have already happened.
The author dismisses TARS as having weak IP and suggests a buyout would have already happened, but does not state a short position.
MED
14:39
Jun 11
Jun 11
The author makes a crude joke about face mites and mentions $TARS without any directional.
The author makes a crude joke about face mites and mentions $TARS without any directional or position-taking language.
LOW
About TARS Analyst Coverage
Buzzberg tracks TARS (Tarsus Pharmaceuticals, Inc.) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 5 total trade ideas tracked. Past 7 days: 3 watch. Latest voices: seedy19tron, A May MD.